Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01508962 · ClinicalTrials.gov registry record

PRE-Symptomatic Studies in Amyotrophic Lateral Sclerosis

A clinical trial of Amyotrophic Lateral Sclerosis, sponsored by University of Miami.

Active
Registry status
100
Enrollment target
1
Study location

NCT01508962: Active study of Amyotrophic Lateral Sclerosis, sponsored by University of Miami.

NCT01508962 is a study of Amyotrophic Lateral Sclerosis that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 100 participants, below the 897-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01508962, a study of Amyotrophic Lateral Sclerosis, is active but no longer recruiting, sponsored by University of Miami.

ACTIVE NOT RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The goal of PRESS-ALS is to study the earliest manifestations of disease in people with early ALS in whom some areas of the body are not yet affected.

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2013-11
Est. Completion 2037-12
University of Miami

721 total trials

What the registry record for NCT01508962 still lists

NCT01508962 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 897-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT01508962 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT01508962 about?

NCT01508962 is a clinical study titled "PRE-Symptomatic Studies in Amyotrophic Lateral Sclerosis". The goal of PRESS-ALS is to study the earliest manifestations of disease in people with early ALS in whom some areas of the body are not yet affected.

What is the current status of trial NCT01508962?

This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2013-11. Estimated completion is 2037-12.

What conditions does trial NCT01508962 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis.

Who is sponsoring clinical trial NCT01508962?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01508962 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01508962's enrollment target sits among peer trials

100 39th of 102 higher than 62 of 102 other Amyotrophic Lateral Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Amyotrophic Lateral Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01508962, the US trial registry maintained by the National Library of Medicine. NCT01508962 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.